Mingyi Xu
- Hepatology top 2%
- Liver physiology and pathology 19
- Hepatitis C virus research 8
- Liver Diseases and Immunity 5
- Liver Disease and Transplantation 4
- Cancer Research top 5%
- MicroRNA in disease regulation 5
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 27
- Hepatitis B Virus Studies 11
-
- Circular RNAs in diseases 5
- Pharmacology top 10%
- Journals
- Gut (1 paper)The FASEB Journal (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Mingyi Xu
53 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 92
- Hepatology 410
- Cancer Research 393
- Epidemiology 511
- Molecular Biology 627
- Pharmacology 65
Countries citing papers authored by Mingyi Xu
This map shows the geographic impact of Mingyi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingyi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingyi Xu more than expected).
Fields of papers citing papers by Mingyi Xu
This network shows the impact of papers produced by Mingyi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingyi Xu. The network helps show where Mingyi Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mingyi Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 11 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 1 | |
| 9 | 2022 | 28 | |
| 10 | 2021 | 42 | |
| 11 | 2021 | 11 | |
| 12 | 2021 | 11 | |
| 13 | 2019 | 43 | |
| 14 | 2018 | 5 | |
| 15 | 2016 | 36 | |
| 16 | 2016 | 7 | |
| 17 | 2015 | 10 | |
| 18 | 2015 | 4 | |
| 19 | 2015 | 16 | |
| 20 | 2014 | 10 |
About Mingyi Xu
Mingyi Xu is a scholar working on Hepatology, Epidemiology and Cancer Research, having authored 56 papers that have together received 1.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (27 papers), Liver physiology and pathology (19 papers), Hepatitis B Virus Studies (11 papers), Hepatitis C virus research (8 papers), MicroRNA in disease regulation (5 papers), Liver Diseases and Immunity (5 papers), Circular RNAs in diseases (5 papers) and Liver Disease and Transplantation (4 papers). The work is most often cited by research in Hepatology (410 citations), Cancer Research (393 citations) and Epidemiology (511 citations). Mingyi Xu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Ying Qu, Qidi Zhang, Xiaobo Cai, Lungen Lu, Zhenzeng Ma, Lungen Lu, Fei Li, Shengzheng Luo, Zhenghong Li and Xiaobo Cai. Their work appears in journals such as Gut, The FASEB Journal and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.